Bulgarian Sopharma Trading becomes majority owner of Lekovit

The biggest pharmaceutical company in Bulgaria looking by revenues, Sopharma Trading, bought a 70% stake in Lekovit Serbia on Friday, August 4, thereby becoming its majority owner. As Lekovit says, the agreement was signed following the unconditional approval of the agreement on the purchase of the majority stake by the Commission for Protection of Competition of Serbia from late July.

The general manager of Lekovit, Dragan Petrovic, is the minority owner with a 30% stake and he will, as said, continue contributing to a further development of the company.

The short-term goal of the new partnership will be to maintain the value of the Serbian company and to develop synergy through successful integration.

The CEO of Sopharma Trading JSC, Dimitar Dimitrov, said that the purchase of Lekovit was the first step towards a regional expansion of the company and that they planned to develop a full business model, such as the one in Bulgaria.

– I am convinced that the combined experience and skills of both teams, as well as our detailed integration program, would create new business opportunities, thereby meeting our mutual goal – Dimitrov said and added that they would “learn from each other and grow together”.

Lekovit was founded in 1992, along with the retail pharmacy chain called FLOS. In 2016, it had 150 employees and operating revenues of over EUR 50 million.

Sopharma Trading is a part of Sopharma Group. In 2015, they initiated a regional expansion to the Serbian market.

Sopharma Trading JSC

Komisija za zaštitu konkurencije Srbije

Sopharma Trading JSC

Sopharma Group

Lekovit

Commission for Protection of Competition of Serbia

Dragan Petrovic

Dimitar Dimitrov

FLOS pharmacies